Florriann C Fehr, Lindsay A Lo, Christopher C Nelson, Lauren Diehl, Zach Walsh
{"title":"Medical Cannabis Use Adjunct to Standard of Care in a Residential Substance Use Recovery Program: A Pilot Study.","authors":"Florriann C Fehr, Lindsay A Lo, Christopher C Nelson, Lauren Diehl, Zach Walsh","doi":"10.15288/jsad.24-00224","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>The purpose of this study was to investigate the experiences of a novel adjunctive medical cannabis (MC) intervention within a residential substance use recovery program.</p><p><strong>Method: </strong>This qualitative study included interviews and validated self-reports with clients (<i>N</i> = 14) at baseline, 1 month, and 3 months after receiving adjunctive medical cannabis treatment in addition to standard of care. Interviews with program staff (<i>N</i> = 7) supplemented the assessment of barriers and facilitators to program delivery.</p><p><strong>Results: </strong>Clients reported that the cannabis substitution program demonstrates promise to help reduce problematic substance use by reducing drug cravings and assisting with pain and other comorbid symptoms. The program also helped to destigmatize MC use. Staff reports highlighted the importance of MC education, clear guidelines for dispensing MC, and an accessible framework for program delivery to facilitate effective uptake of this novel intervention.</p><p><strong>Conclusions: </strong>This study provides preliminary evidence for the feasibility of integrating MC in a supportive residential recovery program. Important factors for success include the provision of cannabis education, developing a clear organizational framework, and establishing evidence-informed policies within the context of substitution therapy and harm reduction. Further research to more formally evaluate integrating MC in residential substance use treatment is encouraged.</p>","PeriodicalId":17159,"journal":{"name":"Journal of studies on alcohol and drugs","volume":" ","pages":"967-976"},"PeriodicalIF":2.2000,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of studies on alcohol and drugs","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.15288/jsad.24-00224","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/10 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"PSYCHOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: The purpose of this study was to investigate the experiences of a novel adjunctive medical cannabis (MC) intervention within a residential substance use recovery program.
Method: This qualitative study included interviews and validated self-reports with clients (N = 14) at baseline, 1 month, and 3 months after receiving adjunctive medical cannabis treatment in addition to standard of care. Interviews with program staff (N = 7) supplemented the assessment of barriers and facilitators to program delivery.
Results: Clients reported that the cannabis substitution program demonstrates promise to help reduce problematic substance use by reducing drug cravings and assisting with pain and other comorbid symptoms. The program also helped to destigmatize MC use. Staff reports highlighted the importance of MC education, clear guidelines for dispensing MC, and an accessible framework for program delivery to facilitate effective uptake of this novel intervention.
Conclusions: This study provides preliminary evidence for the feasibility of integrating MC in a supportive residential recovery program. Important factors for success include the provision of cannabis education, developing a clear organizational framework, and establishing evidence-informed policies within the context of substitution therapy and harm reduction. Further research to more formally evaluate integrating MC in residential substance use treatment is encouraged.
期刊介绍:
The Journal of Studies on Alcohol and Drugs began in 1940 as the Quarterly Journal of Studies on Alcohol. It was founded by Howard W. Haggard, M.D., director of Yale University’s Laboratory of Applied Physiology. Dr. Haggard was a physiologist studying the effects of alcohol on the body, and he started the Journal as a way to publish the increasing amount of research on alcohol use, abuse, and treatment that emerged from Yale and other institutions in the years following the repeal of Prohibition in 1933. In addition to original research, the Journal also published abstracts summarizing other published documents dealing with alcohol. At Yale, Dr. Haggard built a large team of alcohol researchers within the Laboratory of Applied Physiology—including E.M. Jellinek, who became managing editor of the Journal in 1941. In 1943, to bring together the various alcohol research projects conducted by the Laboratory, Dr. Haggard formed the Section of Studies on Alcohol, which also became home to the Journal and its editorial staff. In 1950, the Section was renamed the Center of Alcohol Studies.